Eli Lilly and Co
1LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
IndianapolisIN46285
USAT: +1 317 276-2000
E: jfletcher@lilly.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
47,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,914.80 | 353.10 | 4.67% |
| CAC 40 | 6,863.02 | 237.40 | -3.34% |
| DAX 40 | 19,670.88 | 609.38 | -3.00% |
| Dow JONES (US) | 40,205.73 | 340.20 | -0.84% |
| FTSE 100 | 7,679.48 | 231.05 | -2.92% |
| HKSE | 20,823.72 | 559.23 | 2.76% |
| NASDAQ | 16,836.27 | 285.66 | 1.73% |
| Nikkei 225 | 34,379.85 | 2,665.82 | 8.41% |
| NZX 50 Index | 12,201.43 | 394.88 | 3.34% |
| S&P 500 | 5,381.00 | 398.23 | 7.99% |
| S&P/ASX 200 | 7,712.60 | 337.60 | 4.58% |
| SSE Composite Index | 3,221.16 | 34.35 | 1.08% |